Intestinal failure

D. L. Nguyen, Philbert Van, S. A. McClave, Robert Martindale

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Gut failure is associated with the inability to maintain energy, protein, carbohydrate, lipid, fluid, electrolytes, or micronutrient balances with volitional intake. Gut failure has numerous etiologies of both medical and surgical nature, but most the common is Short Bowel Syndrome (SBS), resulting from surgical resection. Gut failure can be defined as “symptoms and pathophysiologic state associated with inadequate nutrient assimilation as a result of surgical or medical etiology.” The primary goal in the management of gut failure is to achieve gut autonomy, obtaining adequate nutrient balance without parenteral nutrition (PN) supplementation. In addition to the macro and micronutrients provided by PN, fluid and electrolyte replacements are critical to success in attaining gut autonomy. Pharmacologic management must also be considered, and generally involves the use of antidiarrheal/antimotility medications, antisecretory medications, and mucosal growth factors. It should be noted that in situations of gut failure, PN should be considered early and anticipated to be a temporary solution to obtaining adequate nutrition, while concurrent attempts to utilize remaining viable intestine are made. When transitioning PN from hospital to home settings, it is essential that patients and family members providing support are educated on catheter care, infection prevention, hydration, electrolyte, and glycemic control, and the consequences resultant from failure to comply with instructions. Long-term PN use can result in a number of chronic conditions, including hepatic and biliary complications, catheter-related sepsis and thrombosis, renal dysfunction, memory deficit, and metabolic bone disease. Other treatments for gut failure include the use of Octreotide analogs, which have an antidiarrheal effect resulting in the reduction of fluid and electrolyte loss.

Original languageEnglish (US)
Title of host publicationSurgical Metabolism: The Metabolic Care of the Surgical Patient
PublisherSpringer New York
Pages183-198
Number of pages16
ISBN (Print)9781493911219, 9781493911202
DOIs
StatePublished - Jan 1 2014

Fingerprint

Parenteral Nutrition
Electrolytes
Antidiarrheals
Micronutrients
Catheters
Short Bowel Syndrome
Food
Octreotide
Metabolic Bone Diseases
Memory Disorders
Treatment Failure
Intestines
Sepsis
Intercellular Signaling Peptides and Proteins
Thrombosis
Carbohydrates
Kidney
Lipids
Liver
Infection

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Nguyen, D. L., Van, P., McClave, S. A., & Martindale, R. (2014). Intestinal failure. In Surgical Metabolism: The Metabolic Care of the Surgical Patient (pp. 183-198). Springer New York. https://doi.org/10.1007/978-1-4939-1121-9_10

Intestinal failure. / Nguyen, D. L.; Van, Philbert; McClave, S. A.; Martindale, Robert.

Surgical Metabolism: The Metabolic Care of the Surgical Patient. Springer New York, 2014. p. 183-198.

Research output: Chapter in Book/Report/Conference proceedingChapter

Nguyen, DL, Van, P, McClave, SA & Martindale, R 2014, Intestinal failure. in Surgical Metabolism: The Metabolic Care of the Surgical Patient. Springer New York, pp. 183-198. https://doi.org/10.1007/978-1-4939-1121-9_10
Nguyen DL, Van P, McClave SA, Martindale R. Intestinal failure. In Surgical Metabolism: The Metabolic Care of the Surgical Patient. Springer New York. 2014. p. 183-198 https://doi.org/10.1007/978-1-4939-1121-9_10
Nguyen, D. L. ; Van, Philbert ; McClave, S. A. ; Martindale, Robert. / Intestinal failure. Surgical Metabolism: The Metabolic Care of the Surgical Patient. Springer New York, 2014. pp. 183-198
@inbook{88798c47e6e94561ad85e25d9c449e9d,
title = "Intestinal failure",
abstract = "Gut failure is associated with the inability to maintain energy, protein, carbohydrate, lipid, fluid, electrolytes, or micronutrient balances with volitional intake. Gut failure has numerous etiologies of both medical and surgical nature, but most the common is Short Bowel Syndrome (SBS), resulting from surgical resection. Gut failure can be defined as “symptoms and pathophysiologic state associated with inadequate nutrient assimilation as a result of surgical or medical etiology.” The primary goal in the management of gut failure is to achieve gut autonomy, obtaining adequate nutrient balance without parenteral nutrition (PN) supplementation. In addition to the macro and micronutrients provided by PN, fluid and electrolyte replacements are critical to success in attaining gut autonomy. Pharmacologic management must also be considered, and generally involves the use of antidiarrheal/antimotility medications, antisecretory medications, and mucosal growth factors. It should be noted that in situations of gut failure, PN should be considered early and anticipated to be a temporary solution to obtaining adequate nutrition, while concurrent attempts to utilize remaining viable intestine are made. When transitioning PN from hospital to home settings, it is essential that patients and family members providing support are educated on catheter care, infection prevention, hydration, electrolyte, and glycemic control, and the consequences resultant from failure to comply with instructions. Long-term PN use can result in a number of chronic conditions, including hepatic and biliary complications, catheter-related sepsis and thrombosis, renal dysfunction, memory deficit, and metabolic bone disease. Other treatments for gut failure include the use of Octreotide analogs, which have an antidiarrheal effect resulting in the reduction of fluid and electrolyte loss.",
author = "Nguyen, {D. L.} and Philbert Van and McClave, {S. A.} and Robert Martindale",
year = "2014",
month = "1",
day = "1",
doi = "10.1007/978-1-4939-1121-9_10",
language = "English (US)",
isbn = "9781493911219",
pages = "183--198",
booktitle = "Surgical Metabolism: The Metabolic Care of the Surgical Patient",
publisher = "Springer New York",

}

TY - CHAP

T1 - Intestinal failure

AU - Nguyen, D. L.

AU - Van, Philbert

AU - McClave, S. A.

AU - Martindale, Robert

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Gut failure is associated with the inability to maintain energy, protein, carbohydrate, lipid, fluid, electrolytes, or micronutrient balances with volitional intake. Gut failure has numerous etiologies of both medical and surgical nature, but most the common is Short Bowel Syndrome (SBS), resulting from surgical resection. Gut failure can be defined as “symptoms and pathophysiologic state associated with inadequate nutrient assimilation as a result of surgical or medical etiology.” The primary goal in the management of gut failure is to achieve gut autonomy, obtaining adequate nutrient balance without parenteral nutrition (PN) supplementation. In addition to the macro and micronutrients provided by PN, fluid and electrolyte replacements are critical to success in attaining gut autonomy. Pharmacologic management must also be considered, and generally involves the use of antidiarrheal/antimotility medications, antisecretory medications, and mucosal growth factors. It should be noted that in situations of gut failure, PN should be considered early and anticipated to be a temporary solution to obtaining adequate nutrition, while concurrent attempts to utilize remaining viable intestine are made. When transitioning PN from hospital to home settings, it is essential that patients and family members providing support are educated on catheter care, infection prevention, hydration, electrolyte, and glycemic control, and the consequences resultant from failure to comply with instructions. Long-term PN use can result in a number of chronic conditions, including hepatic and biliary complications, catheter-related sepsis and thrombosis, renal dysfunction, memory deficit, and metabolic bone disease. Other treatments for gut failure include the use of Octreotide analogs, which have an antidiarrheal effect resulting in the reduction of fluid and electrolyte loss.

AB - Gut failure is associated with the inability to maintain energy, protein, carbohydrate, lipid, fluid, electrolytes, or micronutrient balances with volitional intake. Gut failure has numerous etiologies of both medical and surgical nature, but most the common is Short Bowel Syndrome (SBS), resulting from surgical resection. Gut failure can be defined as “symptoms and pathophysiologic state associated with inadequate nutrient assimilation as a result of surgical or medical etiology.” The primary goal in the management of gut failure is to achieve gut autonomy, obtaining adequate nutrient balance without parenteral nutrition (PN) supplementation. In addition to the macro and micronutrients provided by PN, fluid and electrolyte replacements are critical to success in attaining gut autonomy. Pharmacologic management must also be considered, and generally involves the use of antidiarrheal/antimotility medications, antisecretory medications, and mucosal growth factors. It should be noted that in situations of gut failure, PN should be considered early and anticipated to be a temporary solution to obtaining adequate nutrition, while concurrent attempts to utilize remaining viable intestine are made. When transitioning PN from hospital to home settings, it is essential that patients and family members providing support are educated on catheter care, infection prevention, hydration, electrolyte, and glycemic control, and the consequences resultant from failure to comply with instructions. Long-term PN use can result in a number of chronic conditions, including hepatic and biliary complications, catheter-related sepsis and thrombosis, renal dysfunction, memory deficit, and metabolic bone disease. Other treatments for gut failure include the use of Octreotide analogs, which have an antidiarrheal effect resulting in the reduction of fluid and electrolyte loss.

UR - http://www.scopus.com/inward/record.url?scp=84961302351&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961302351&partnerID=8YFLogxK

U2 - 10.1007/978-1-4939-1121-9_10

DO - 10.1007/978-1-4939-1121-9_10

M3 - Chapter

SN - 9781493911219

SN - 9781493911202

SP - 183

EP - 198

BT - Surgical Metabolism: The Metabolic Care of the Surgical Patient

PB - Springer New York

ER -